The binding characteristics of a human bladder recombinant P<sub>2X</sub> purinoceptor, labelled with [<sup>3</sup>H]‐αβmeATP, [<sup>35</sup>S]‐ATPγS or <sup>33</sup>[P]‐ATP

Anton D. Michel, P.P.A. Humphrey, Soledad Valera, Gary Buell(Unknown), Annmarie Surprenant(University of Manchester), Kenneth Lundström(Nanotherapeutics (United States))
British Journal of Pharmacology
March 1, 1996
Cited by 34


Related Papers